Okhunov Zhamshid, Moreira Daniel M, Del Junco Michael, Abedi Garen, Lobko Igor I, Kaler Kamaljot S, Nguyen Nobel D, Youssef Ramy, Uchio Edward, Kavoussi Louis R, Landman Jaime
1 Department of Urology, University of California , Irvine, Orange, California.
2 Department of Urology, Mayo Clinic , Rochester, Minnesota.
J Endourol. 2017 Jan;31(1):7-13. doi: 10.1089/end.2016.0684. Epub 2016 Dec 7.
To determine the incidence and predictors of major complications in patients undergoing percutaneous cryoablation (PCA) for small renal masses.
We performed a retrospective analysis of patients undergoing PCA from 2005 to 2012. We analyzed demographic, radiographic, and complication data. We defined complications as any deviation from the expected postoperative course. We determined predictors of complications.
A total of 190 patients were included in the study. The mean age was 69 years, and 132 (69%) were males. The mean tumor diameter was 2.2 cm (0.8-4.0 cm). The mean number of probes utilized per procedure was 2.3. We observed 16 (8.4%) complications including 14 Clavien grade I, which includes 6 (2%) large renal/retroperitoneal hematomas, 4 (2%) pneumothoraxes, 2 (1%) urinary tract infections, and 2 (1%) atrial fibrillations. There were two (1%) Clavien grade II complications (intestinal perforations). In univariable analysis, larger tumors and more probes were associated with higher risk of complications (all ps < 0.05). In multivariable analysis, larger tumor dimension (odds ratio [OR] = 2.85; 95% confidence interval [CI] = 1.34, 6.05; p = 0.006) was independently associated with major complications. After multivariable adjustments for patient's characteristics such as age, gender, American Society of Anesthesiologists, year of surgery, and histopathology, larger tumor dimension (OR = 2.85; 95%CI = 1.34, 6.05; p = 0.006) and more cryoablation probes (OR = 1.94; 95%CI = 1.36, 2.75; p < 0.001) were independently associated with higher risk of major complications.
In a cohort of patients undergoing PCA for T1a small renal mass, larger tumor dimension and more cryoablation probes were independently associated with higher risk of complication. Although PCA is relatively safe and the major complications are infrequent, careful patient selection is crucial.
确定接受经皮冷冻消融术(PCA)治疗小肾肿块患者的主要并发症发生率及预测因素。
我们对2005年至2012年接受PCA的患者进行了回顾性分析。我们分析了人口统计学、影像学和并发症数据。我们将并发症定义为任何与预期术后病程的偏差。我们确定了并发症的预测因素。
共有190例患者纳入研究。平均年龄为69岁,132例(69%)为男性。平均肿瘤直径为2.2厘米(0.8 - 4.0厘米)。每次手术使用的平均探针数为2.3根。我们观察到16例(8.4%)并发症,包括14例Clavien I级,其中包括6例(2%)较大的肾/腹膜后血肿、4例(2%)气胸、2例(1%)尿路感染和2例(1%)心房颤动。有2例(1%)Clavien II级并发症(肠穿孔)。在单变量分析中,较大的肿瘤和更多的探针与更高的并发症风险相关(所有p值<0.05)。在多变量分析中,较大的肿瘤尺寸(比值比[OR]=2.85;95%置信区间[CI]=1.34,6.05;p = 0.006)与主要并发症独立相关。在对患者特征如年龄、性别、美国麻醉医师协会分级、手术年份和组织病理学进行多变量调整后,较大的肿瘤尺寸(OR = 2.85;95%CI = 1.34,6.05;p = 0.006)和更多的冷冻消融探针(OR = 1.94;95%CI = 1.36,2.75;p < 0.001)与更高的主要并发症风险独立相关。
在一组接受PCA治疗T1a期小肾肿块的患者中,较大的肿瘤尺寸和更多的冷冻消融探针与更高的并发症风险独立相关。虽然PCA相对安全且主要并发症不常见,但仔细的患者选择至关重要。